BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Katagiri M, Nishikawa S, Hokari K, Takeda H. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol. 2000;12:635-640. [PMID: 10912481 DOI: 10.1097/00042737-200012060-00010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Quan C, Talley NJ. Management of Peptic Ulcer Disease Not Related to Helicobacter pylori or NSAIDs. American Journal of Gastroenterology 2002;97:2950-61. [DOI: 10.1111/j.1572-0241.2002.07068.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
2 Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Leong RW, Chan HL, Wu JC, Leung WK. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005;128:1845-1850. [PMID: 15940620 DOI: 10.1053/j.gastro.2005.03.026] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
3 Kim JJ, Kim N, Lee BH, Kang JM, Seo P, Lim MK, Kwon JH, Song BJ, Lee JW, Lee SH. [Risk factors for development and recurrence of peptic ulcer disease]. Korean J Gastroenterol. 2010;56:220-228. [PMID: 20962557 DOI: 10.4166/kjg.2010.56.4.220] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
4 Schlansky B, Hwang JH. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy. J Gastroenterol 2009;44 Suppl 19:44-52. [PMID: 19148793 DOI: 10.1007/s00535-008-2275-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
5 Chung CS, Chiang TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med. 2015;30:559-570. [PMID: 26354049 DOI: 10.3904/kjim.2015.30.5.559] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
6 Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol. 2004;16:779-783. [PMID: 15256980 DOI: 10.1097/01.meg.0000108367.19243.73] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
7 Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, Lai LH, Chow DK, Siu DK, Lui YN. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525-531. [PMID: 19445937 DOI: 10.1053/j.gastro.2009.05.006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
8 Wong SN, Sollano JD, Chan MM, Carpio RE, Tady CS, Ismael AE, Judan-ruiz EA, Ang VN, Go JT, Lim VY, Perez JY, Alvarez SZ. Changing trends in peptic ulcer prevalence in a tertiary care setting in the Philippines: A seven-year study. J Gastroenterol Hepatol 2005;20:628-32. [DOI: 10.1111/j.1440-1746.2005.03719.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
9 Musumba C, Jorgensen A, Sutton L, Van Eker D, Moorcroft J, Hopkins M, Pritchard DM, Pirmohamed M. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther. 2012;36:48-56. [PMID: 22554233 DOI: 10.1111/j.1365-2036.2012.05118.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
10 Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009;30:791-815. [PMID: 19706147 DOI: 10.1111/j.1365-2036.2009.04105.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
11 Seo M, Okada M, Shirotani T, Nishimura H, Maeda K, Aoyagi K, Sakisaka S. Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J Clin Gastroenterol 2002;34:129-34. [PMID: 11782605 DOI: 10.1097/00004836-200202000-00005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
12 Iwakiri R, Fujimoto K. Roles of NSAIDs and aspirin in bleeding peptic ulcers: NSAIDs, aspirin and peptic ulcers. Clin J Gastroenterol 2008;1:33-9. [DOI: 10.1007/s12328-008-0011-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Tan HJ, Goh KL. Changing epidemiology of Helicobacter pylori in Asia. J Dig Dis. 2008;9:186-189. [PMID: 18959588 DOI: 10.1111/j.1751-2980.2008.00344.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yoon H, Kim SG, Jung HC, Song IS. High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up. Gut Liver. 2013;7:175-181. [PMID: 23560153 DOI: 10.5009/gnl.2013.7.2.175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
15 Yamaguchi D, Tominaga N, Miyahara K, Tsuruoka N, Sakata Y, Takeuchi Y, Matsunaga T, Hidaka H, Akutagawa T, Noda T, Ogata S, Tsunada S, Esaki M. Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study. Can J Gastroenterol Hepatol 2021;2021:6672440. [PMID: 34095017 DOI: 10.1155/2021/6672440] [Reference Citation Analysis]
16 Niv Y, Boltin D. Secreted and membrane-bound mucins and idiopathic peptic ulcer disease. Digestion. 2012;86:258-263. [PMID: 23075498 DOI: 10.1159/000341423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chan FK, Leung WK. Peptic-ulcer disease. Lancet. 2002;360:933-941. [PMID: 12354485 DOI: 10.1016/s0140-6736(02)11030-0] [Cited by in Crossref: 151] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
18 Nishino M, Sugimoto M, Kodaira C, Yamade M, Uotani T, Shirai N, Ikuma M, Tanaka T, Sugimura H, Hishida A, Furuta T. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. J Clin Pharmacol 2011;51:1079-86. [PMID: 20663999 DOI: 10.1177/0091270010376194] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
19 Yakoob J, Jafri W, Jafri N, Islam M, Abid S, Hamid S, AliShah H, Shaikh H. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenterol 2005; 11(23): 3562-3565 [PMID: 15962375 DOI: 10.3748/wjg.v11.i23.3562] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
20 Kanno T, Iijima K, Abe Y, Yagi M, Asonuma S, Ohyauchi M, Ito H, Koike T, Shimosegawa T. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. J Gastroenterol Hepatol. 2015;30:842-848. [PMID: 25532720 DOI: 10.1111/jgh.12876] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
21 van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:209-224. [PMID: 18346679 DOI: 10.1016/j.bpg.2007.10.011] [Cited by in Crossref: 200] [Cited by in F6Publishing: 164] [Article Influence: 14.3] [Reference Citation Analysis]
22 Adamopoulos AB, Efstathiou SP, Tsioulos DI, Tzamouranis DG, Tsiakou AG, Tiniakos D, Mountokalakis TD. Bleeding duodenal ulcer: comparison between Helicobacter pylori positive and Helicobacter pylori negative bleeders. Dig Liver Dis. 2004;36:13-20. [PMID: 14971811 DOI: 10.1016/j.dld.2003.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
23 Chow DK, Sung JJ. Is the prevalence of idiopathic ulcers really on the increase? Nat Rev Gastroenterol Hepatol 2007;4:176-7. [DOI: 10.1038/ncpgasthep0769] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
24 Kang JM, Kim N, Lee BH, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents. Scand J Gastroenterol. 2011;46:1295-1301. [PMID: 21815866 DOI: 10.3109/00365521.2011.605468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
25 Niv Y. H. pylori/NSAID--negative peptic ulcer--the mucin theory. Med Hypotheses. 2010;75:433-435. [PMID: 20444554 DOI: 10.1016/j.mehy.2010.04.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kim JJ, Kim N, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH. [Clinical characteristics of patients diagnosed as peptic ulcer disease in the third referral center in 2007]. Korean J Gastroenterol. 2012;59:338-346. [PMID: 22617527 DOI: 10.4166/kjg.2012.59.5.338] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
27 Mohammadi M, Talebi Bezmin Abadi A, Rahimi F, Forootan M. Helicobacter heilmannii Colonization Is Associated with High Risk for Gastritis. Archives of Medical Research 2019;50:423-7. [DOI: 10.1016/j.arcmed.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kamiya T, Joh T, Sollano JD, Zhu Q, Kachintorn U, Aziz Rani A, Hahm KB, Takahashi S, Kinoshita Y, Matsumoto T, Naito Y, Takeuchi K, Arakawa T, Terano A. Consensus of the present and prospects on endoscopic diagnosis and treatment in East asian countries. Diagn Ther Endosc 2012;2012:808365. [PMID: 23093833 DOI: 10.1155/2012/808365] [Reference Citation Analysis]
29 Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004;9:9-16. [PMID: 15156899 DOI: 10.1111/j.1083-4389.2004.00194.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
30 Iijima K, Kanno T, Koike T, Shimosegawa T. Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: Negative idiopathic ulcers in Asia. World J Gastroenterol 2014; 20(3): 706-713 [PMID: 24574744 DOI: 10.3748/wjg.v20.i3.706] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
31 Rasane RK, Horn CB, Coleoglou Centeno AA, Fiore NB, Torres Barboza M, Zhang Q, Bochicchio KM, Punch LJ, Bochicchio GV, Ilahi ON. Are Patients with Perforated Peptic Ulcers Who are Negative for Helicobacter pylori at a Greater Risk? Surg Infect (Larchmt). 2019;20:444-448. [PMID: 30939075 DOI: 10.1089/sur.2018.249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Kamada T, Hata J, Kusunoki H, Sugiu K, Tanimoto T, Mihara M, Hamada H, Kido S, Dongmei Q, Haruma K. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer. Journal of Gastroenterology and Hepatology 2006;21:98-102. [DOI: 10.1111/j.1440-1746.2005.04219.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
33 Nakayama M, Iwakiri R, Hara M, Ootani H, Shimoda R, Tsunada S, Sakata H, Fujimoto K. Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol. 2009;44:912-918. [PMID: 19436943 DOI: 10.1007/s00535-009-0074-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
34 Sone Y, Kumada T, Toyoda H, Yokoyama M, Kato M, Asaka M. Eradicating Helicobacter pylori in Peptic Ulcer Disease Reduces Medical Costs in the Community. Helicobacter 2008;13:346-51. [DOI: 10.1111/j.1523-5378.2008.00623.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa M. Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Biochem Nutr. 2009;45:248-253. [PMID: 19794936 DOI: 10.3164/jcbn.09-24] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
36 Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter. 2004;9:249-254. [PMID: 15165261 DOI: 10.1111/j.1083-4389.2004.00219.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
37 Kamada T, Haruma K, Kusunoki H, Miyamoto M, Ito M, Kitadai Y, Yoshihara M, Chayama K, Tahara K, Kawamura Y. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci. 2003;48:644-651. [PMID: 12741450 DOI: 10.1016/s0016-5085(03)82254-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Ikeda S, Tamamuro T, Hamashima C, Asaka M. Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan. Aliment Pharmacol Ther. 2001;15:1777-1785. [PMID: 11683692 DOI: 10.1046/j.1365-2036.2001.01106.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
39 Kang JM, Seo PJ, Kim N, Lee BH, Kwon J, Lee DH, Jung HC. Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center. Scand J Gastroenterol. 2012;47:36-42. [PMID: 22126650 DOI: 10.3109/00365521.2011.639083] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
40 Seo JH, Hong SJ, Kim JH, Kim BW, Jee SR, Chung WC, Shim KN, Baik GH, Kim SS, Kim SG, Kim JI. Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori. Gut Liver 2016;10:719-25. [PMID: 27114412 DOI: 10.5009/gnl15262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
41 Kono Y, Okada H, Takenaka R, Miura K, Kanzaki H, Hori K, Kita M, Tsuzuki T, Kawano S, Kawahara Y, Yamamoto K. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study. Gut Liver 2016;10:69-75. [PMID: 26087789 DOI: 10.5009/gnl14372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Kim Y, Yokoyama S, Watari J, Hori K, Yamasaki T, Okugawa T, Toyoshima F, Kondo T, Sakurai J, Tanaka J, Tomita T, Oshima T, Fukui H, Abe T, Matsumoto T, Miwa H. Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. J Gastroenterol 2012;47:904-11. [PMID: 22350702 DOI: 10.1007/s00535-012-0553-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
43 Chen TS, Luo JC, Chang FY. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol. 2010;25:919-922. [PMID: 20074147 DOI: 10.1111/j.1440-1746.2009.06139.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
44 Goh KL, Wong HT, Lim CH, Rosaida MS. Time trends in peptic ulcer, erosive reflux oesophagitis, gastric and oesophageal cancers in a multiracial Asian population. Aliment Pharmacol Ther 2009;29:774-80. [PMID: 19183160 DOI: 10.1111/j.1365-2036.2009.03930.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
45 Hobsley M, Tovey FI, Holton J. Precise role of H pylori in duodenal ulceration. World J Gastroenterol 2006; 12(40): 6413-6419 [PMID: 17072972 DOI: 10.3748/wjg.v12.i40.6413] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
46 Ootani H, Iwakiri R, Shimoda R, Nakahara S, Amemori S, Fujise T, Kikkawa A, Tsunada S, Sakata H, Fujimoto K. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol. 2006;41:41-46. [PMID: 16501856 DOI: 10.1007/s00535-005-1720-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
47 Yuan Y, Padol IT, Hunt RH. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol. 2006;3:80-89. [PMID: 16456574 DOI: 10.1038/ncpgasthep0393] [Cited by in Crossref: 127] [Cited by in F6Publishing: 106] [Article Influence: 7.9] [Reference Citation Analysis]
48 Cheung DY, Jung HY, Song HJ, Jung SW, Jung HC; Korean College of Helicobacter and Upper Gastrointestinal Research., Korean Association of Gastroenterology. [Guidelines of treatment for non-bleeding peptic ulcer disease]. Korean J Gastroenterol 2009;54:285-97. [PMID: 19934610 DOI: 10.4166/kjg.2009.54.5.285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
49 Yamane T, Ishii T, Umeda A, Shimao H. Evaluation of Six Cases of Idiopathic Gastric Antral Ulcer. Gastroenterology Res 2012;5:120-6. [PMID: 27785190 DOI: 10.4021/gr437w] [Reference Citation Analysis]
50 Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24:299-309. [PMID: 24234733 DOI: 10.1007/s11695-013-1118-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 83] [Article Influence: 13.9] [Reference Citation Analysis]
51 Shinji A, Sano K, Hamano H, Unno H, Fukushima M, Nakamura N, Akamatsu T, Kawa S, Kiyosawa K. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59:506-511. [PMID: 15044886 DOI: 10.1016/s0016-5107(03)02874-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
52 Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol. 2009;23:3-9. [PMID: 19258182 DOI: 10.1016/j.bpg.2008.11.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
53 Yamaguchi D, Sakata Y, Yoshida H, Furukawa NE, Tsuruoka N, Higuchi T, Watanabe A, Shimoda R, Tsunada S, Iwakiri R, Fujimoto K. Effectiveness of Endoscopic Hemostasis with Soft Coagulation for Non-Variceal Upper Gastrointestinal Bleeding over a 12-Year Period. Digestion 2017;95:319-26. [PMID: 28564642 DOI: 10.1159/000477439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
54 Kamada T, Haruma K, Kusunoki H, Miyamoto M, Ito M, Kitadai Y, Yoshihara M, Chayama K, Tahara K, Kawamura Y. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci. 2003;48:644-651. [PMID: 12741450 DOI: 10.1023/a:1022808003014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
55 Yamanaka K, Miyatani H, Yoshida Y, Asabe S, Yoshida T, Nakano M, Obara S, Endo H. Hemorrhagic gastric and duodenal ulcers after the Great East Japan Earthquake Disaster. World J Gastroenterol 2013; 19(42): 7426-7432 [PMID: 24259974 DOI: 10.3748/wjg.v19.i42.7426] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 Wong GLH, Lau LHS, Ching JYL, Tse YK, Ling RHY, Wong VWS, Chiu PWY, Lau JYW, Chan FKL. Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial. Gut 2020;69:652-7. [PMID: 31229990 DOI: 10.1136/gutjnl-2019-318715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
57 Saini SD, Eisen G, Mattek N, Schoenfeld P. Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol 2008;103:1920-5. [PMID: 18796092 DOI: 10.1111/j.1572-0241.2008.01945.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
58 Charpignon C, Lesgourgues B, Pariente A, Nahon S, Pelaquier A, Gatineau-Sailliant G, Roucayrol AM, Courillon-Mallet A. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther. 2013;38:946-954. [PMID: 23981105 DOI: 10.1111/apt.12465] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
59 Jang HJ, Choi MH, Shin WG, Kim KH, Chung YW, Kim KO, Park CH, Baek IH, Baik KH, Kae SH. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci. 2008;53:1527-1531. [PMID: 17932759 DOI: 10.1007/s10620-007-0028-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
60 van Leerdam ME, Tytgat GN. Review article: Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther. 2002;16 Suppl 1:66-78. [PMID: 11849131 DOI: 10.1046/j.1365-2036.2002.0160s1066.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
61 Goenka MK, Majumder S, Sethy PK, Chakraborty M. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India. Indian J Gastroenterol. 2011;30:33-37. [PMID: 21424697 DOI: 10.1007/s12664-011-0085-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wong GL, Au KW, Lo AO, Tse YK, Ching JY, To KF, Chan FK. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Clin Gastroenterol Hepatol. 2012;10:1124-1129. [PMID: 22732269 DOI: 10.1016/j.cgh.2012.06.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
63 Nishino M, Sugimoto M, Kodaira C, Yamade M, Shirai N, Ikuma M, Tanaka T, Sugimura H, Hishida A, Furuta T. Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers. Dig Dis Sci. 2010;55:1627-1636. [PMID: 19672708 DOI: 10.1007/s10620-009-0920-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
64 Kono Y, Kawano S, Takaki A, Shimomura Y, Onji M, Ishikawa H, Takahashi S, Horii J, Kobayashi S, Kawai D, Yamamoto K, Okada H. Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs. J Gastroenterol Hepatol 2017;32:136-45. [PMID: 27118323 DOI: 10.1111/jgh.13424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]